Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

This publication has 7 references indexed in Scilit:

• The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
  Blood, 2006
• The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)
  Blood, 2006
• Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
  Blood, 2005
• Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
  British Journal of Haematology, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera
  The Hematology Journal, 2004
• The World Health Organization (WHO) classification of the myeloid neoplasms
  Blood, 2002